1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Systemic Sclerosis With Lung Involvement: new trials by email Literature Review of Systemic Sclerosis With Lung Involvement trials Research Report on Systemic Sclerosis With Lung Involvement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard Therapy C-CAR168 - Systemic Sclerosis (SSc), Systemic Sclerosis | Phase 1 | Not yet recruiting | AbelZeta Inc. | 12 | 2027-03-01 | 2026-10-13 |
Autoimmune Diseases (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1)
Connective Tissue Diseases (1) · Immune System Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
AbelZeta Inc. (1)
United States (1)
Yihong Yao, PhD (1)